- Home
- BCBP vs CRVS Comparison
BCBP vs CRVS Comparison
Compare BCBP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- CRVS
- Stock Information
- Founded
- BCBP 2000
- CRVS 2014
- Country
- BCBP United States
- CRVS United States
- Employees
- BCBP N/A
- CRVS N/A
- Industry
- BCBP Savings Institutions
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- CRVS Health Care
- Exchange
- BCBP Nasdaq
- CRVS Nasdaq
- Market Cap
- BCBP 211.6M
- CRVS 161.4M
- IPO Year
- BCBP N/A
- CRVS 2016
- Fundamental
- Price
- BCBP $12.52
- CRVS $5.78
- Analyst Decision
- BCBP Hold
- CRVS Buy
- Analyst Count
- BCBP 2
- CRVS 4
- Target Price
- BCBP $13.50
- CRVS $10.83
- AVG Volume (30 Days)
- BCBP 52.5K
- CRVS 468.1K
- Earning Date
- BCBP 10-17-2024
- CRVS 11-05-2024
- Dividend Yield
- BCBP 5.13%
- CRVS N/A
- EPS Growth
- BCBP N/A
- CRVS N/A
- EPS
- BCBP 1.20
- CRVS N/A
- Revenue
- BCBP $91,235,000.00
- CRVS N/A
- Revenue This Year
- BCBP N/A
- CRVS N/A
- Revenue Next Year
- BCBP $10.69
- CRVS N/A
- P/E Ratio
- BCBP $10.44
- CRVS N/A
- Revenue Growth
- BCBP N/A
- CRVS N/A
- 52 Week Low
- BCBP $9.19
- CRVS $1.05
- 52 Week High
- BCBP $13.90
- CRVS $6.15
- Technical
- Relative Strength Index (RSI)
- BCBP 61.33
- CRVS 79.19
- Support Level
- BCBP $11.66
- CRVS $3.90
- Resistance Level
- BCBP $12.08
- CRVS $4.75
- Average True Range (ATR)
- BCBP 0.31
- CRVS 0.40
- MACD
- BCBP 0.01
- CRVS 0.09
- Stochastic Oscillator
- BCBP 89.90
- CRVS 83.56
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection, and automated teller services.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).